title: Remission of an extensively pre-treated relapsing/refractory ALK-positive anaplastic large cell lymphoma following metronomic therapy.
authors.affiliation: a Department of Lymphoma , Head and Neck Cancer, the Affiliated Hospital of Academy of Military Medical Sciences , Beijing , PR China ;
authors.forename: Shunzong
authors.initials: S
authors.lastname: Yuan
authors.affiliation: b Comprehensive Cancer Center, Division of Hematology , The James Cancer Hospital, The Ohio State University , Columbus , OH , USA.
authors.forename: Jianhua
authors.initials: J
authors.lastname: Yu
authors.affiliation: b Comprehensive Cancer Center, Division of Hematology , The James Cancer Hospital, The Ohio State University , Columbus , OH , USA.
authors.forename: Brad
authors.initials: B
authors.lastname: Haverkos
authors.affiliation: a Department of Lymphoma , Head and Neck Cancer, the Affiliated Hospital of Academy of Military Medical Sciences , Beijing , PR China ;
authors.forename: Hang
authors.initials: H
authors.lastname: Su
mesh_terms: D003131:Combined Modality Therapy; D019008:Drug Resistance, Neoplasm; D006801:Humans; D017728:Lymphoma, Large-Cell, Anaplastic / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D000072078:Positron Emission Tomography Computed Tomography; D012008:Recurrence; D012074:Remission Induction; D016896:Treatment Outcome